Intended for healthcare professionals

Letters Care of rare diseases

Transfer of high cost drugs to NICE risks fragmentation of care of rare diseases

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e5727 (Published 24 August 2012) Cite this as: BMJ 2012;345:e5727